CI-AKI
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with coronary heart disease undergoing elective PCI; 2. Aged >18 years; 3. Only iodixanol was used in the procedure; 4. Sign the informed consent file.
Exclusion criteria
Exclusion criteria: 1. Has a history of mental illness and is not yet in control; 2. With uncontrolled hyperthyroidism; 3. End-stage renal disease requiring dialysis; eGFR =70% or bilateral renal artery stenosis >=50%; 5. Severe liver dysfunction: alanine aminotransferase and/or aspartate aminotransferase >= 3 times the upper limit of the normal reference value; 6. Acute active bleeding; 7. Contrast allergy; 8. Previous serious adverse reactions to iodine contrast agent and iodine-containing food; 9. Cardiogenic shock; 10. Intraoperative deaths; 11. Expected survival period of less than 1 year in the history of Malignant disease; 12. Any other factors in the study that are not suitable for inclusion in the study or affect the subject's participation in or completion of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CI-AKI; | — |
Secondary
| Measure | Time frame |
|---|---|
| All-cause mortality;Non fatal MI;New renal replacement therapy; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Army Medical University